Two distinct types of cancer of different origin may be mixed in gastroesophageal junction adenocarcinomas in Japan: Evidence from direct evaluation of gastric acid secretion

Scandinavian Journal of Gastroenterology

Volumn 46, Issue 6, 2011, Pages 710-719

  Horii, Toru ^a   Koike, Tomoyuki ^a   Abe, Yasuhiko ^a   Kikuchi, Ryosuke ^a   Unakami, Hiroyuki ^a   Iijima, Katsunori ^a   Imatani, Akira ^a   Ohara, Shuichi ^a   Shimosegawa, Tooru ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Esophageal disorders; gastritis; gastroduodenal clinical; Helicobacter pylori; oncology clinical

Indexed keywords

GASTRIN;

ADULT; ARTICLE; BARRETT ESOPHAGUS; BARRETT ESOPHAGUS CANCER; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; EVALUATION; FEMALE; HELICOBACTER INFECTION; HISTOLOGY; HUMAN; JAPAN; LOWER ESOPHAGUS SPHINCTER; MALE; MULTIPLE CANCER; PATHOLOGY; PREVALENCE; PRIORITY JOURNAL; STOMACH ACID SECRETION; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; AGED; BARRETT ESOPHAGUS; CASE-CONTROL STUDIES; ENDOSCOPY, DIGESTIVE SYSTEM; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FEMALE; GASTRIC ACID; GASTRINS; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; JAPAN; MALE; MIDDLE AGED; PREVALENCE; SEVERITY OF ILLNESS INDEX;

EID: 79955950702     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2011.565069     Document Type: Article

References (47)

1. Hassall E. Barrett's esophagus: congenital or acquired? Am J Gastroenterol 1993;88:819-24.
2. Eisen GM, Sandler RS, Murray S, Gottfried M. The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. Am J Gastroenterol 1997;92:27-31. (Pubitemid 27027023)
3. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 1994;25:982-93.
4. Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RK. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 1994;344:1533-6. (Pubitemid 24357710)
5. Chow WH, Finkle WD,McLaughlin JK, Frankl H, Ziel HK, Fraumeni JF Jr. The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA 1995;274:474-7.
6. Weston AP, Badr AS, Topalovski M, Cherian R, Dixon A, Hassanein RS, et al. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma. Am J Gastroenterol 2000;95: 387-94. (Pubitemid 30106166)
7. Corley DA, Kubo A, Levin TR, Block G, Habel L, Zhao W, et al. Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study. Gut 2008;57: 727-33. (Pubitemid 351716961)
8. Abe Y, Ohara S, Koike T, Sekine H, Iijima K, Kawamura M, et al. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan. Am J Gastroenterol 2004;99:1213-21. (Pubitemid 39062254)
9. Koike T, Ohara S, Sekine H, Iijima K, Abe Y, Kato K, et al. Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut 2001;49: 330-4. (Pubitemid 32802565)
10. Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res (Phila Pa) 2008;1:329-38.
11. McColl KE, Watabe H, Derakhshan MH. Role of gastric atrophy in mediating negative association between Helicobacter pylori infection and reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma. Gut 2008; 57:721-3. (Pubitemid 351716958)
12. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005;97:142-6. (Pubitemid 40277094)
13. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-53. (Pubitemid 28525384)
14. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-9.
15. Pera M, Manterola C, Vidal O, Grande L. Epidemiology of esophageal adenocarcinoma. J Surg Oncol 2005;92: 151-9. (Pubitemid 41779297)
16. Kobayashi T, Kikuchi S, Lin Y, Yagyu K, Obata Y, Ogihara A, et al. Trends in the incidence of gastric cancer in Japan and their associations with Helicobacter pylori infection and gastric mucosal atrophy. Gastric Cancer 2004;7:233-9.
17. Inomata Y, Koike T, Ohara S, Abe Y, Sekine H, Iijima K, et al. Preservation of gastric acid secretion may be important for the development of gastroesophageal junction adenocarcinoma in Japanese people, irrespective of the H. pylori infection status. Am J Gastroenterol 2006;101:926-33. (Pubitemid 43725303)
18. Derakhshan MH, Malekzadeh R, Watabe H, Yazdanbod A, Fyfe V, Kazemi A, et al. Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut 2008;57: 298-305. (Pubitemid 351288093)
19. Nunobe S, Nakanishi Y, Taniguchi H, Sasako M, Sano T, Kato H, et al. Two distinct pathways of tumorigenesis of adenocarcinomas of the esophagogastric junction, related or unrelated to intestinal metaplasia. Pathol Int 2007;57: 315-21. (Pubitemid 46849030)
20. Siewert JR, Feith M. Adenocarcinoma of the esophagogastric junction: competition between Barrett and gastric cancer. J Am Coll Surg 2007;205:S49-53. (Pubitemid 47488916)
21. Driessen A, Van Raemdonck D, De Leyn P, Filez L, Peeters M, Winnepenninckx V, et al. Are carcinomas of the cardia oesophageal or gastric adenocarcinomas? Eur J Cancer 2003;39:2487-94. (Pubitemid 37340161)
22. Chandrasoma P, Wickramasinghe K, Ma Y, DeMeester T. Adenocarcinomas of the distal esophagus and "gastric cardia" are predominantly esophageal carcinomas. Am J Surg Pathol 2007;31:569-75. (Pubitemid 46569041)
23. Crane SJ, Locke GR 3rd, Harmsen WS, Diehl NN, Zinsmeister AR, Melton LJ 3rd, et al. Subsite-specific risk factors for esophageal and gastric adenocarcinoma. Am J Gastroenterol 2007;102:1596-602. (Pubitemid 47206680)
24. Hansen S, Vollset SE, Derakhshan MH, Fyfe V, Melby KK, Aase S, et al. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status. Gut 2007;56:918-25. (Pubitemid 46999074)
25. Lagergren J, Bergström R, Lindgren A, Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-31. (Pubitemid 29142625)
26. Japan Esophageal Society. Japanese classification of esophageal cancer. 10th ed. Tokyo: Kanehara & Co. Ltd; 2008.
27. Naef AP, Savary M, Ozzello L. Columnar-lined lower esophagus: an acquired lesion withmalignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas. J Thorac Cardiovasc Surg 1975;70:826-35.
28. Barrett NR. Chronic peptic ulcer of the oesophagus and 'oesophagitis'. Br J Surg 1950;38:175-82.
29. Takubo K, Aida J, Sawabe M, Arai T, Kato H, Pech O, et al. The normal anatomy around the oesophagogastric junction: a histopathologic view and its correlation with endoscopy. Best Pract Res Clin Gastroenterol 2008;22:569-83. (Pubitemid 352016342)
30. Amano Y, Ishimura N, Furuta K, Takahashi Y, Chinuki D, Mishima Y, et al. Which landmark results in a moreconsistent diagnosis of Barrett's esophagus, the gastric folds or the palisade vessels? Gastrointest Endosc 2006;64: 206-11. (Pubitemid 44081905)
31. Cameron AJ, Lomboy CT, Pera M, Carpenter HA. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995;109:1541-6.
32. Belhocine K, Galmiche JP. Epidemiology of the complications of gastroesophageal reflux disease. Dig Dis 2009; 27:7-13.
33. Conio M, Filiberti R, Blanchi S, Ferraris R, Marchi S, Ravelli P, et al. Risk factors for Barrett's esophagus: a case-control study. Int J Cancer 2002;97:225-9. (Pubitemid 34019959)
34. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005;143: 199-211. (Pubitemid 41076753)
35. Hirota WK, Loughney TM, Lazas DJ, Maydonovitch CL, Rholl V, Wong RK. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 1999;116:277-85. (Pubitemid 29055349)
36. Achkar JP, Post AB, Achkar E, Carey WD. Risk of extraesophageal malignancy in patients with adenocarcinoma arising in Barrett's esophagus. Am J Gastroenterol 1995; 90:39-43.
37. Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996;111:85-92. (Pubitemid 26226887)
38. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161-81.
39. Iijima K, Ohara S, Sekine H, Koike T, Kubota Y, Kato K, et al. A new endoscopic method of gastric acid secretory testing. Am J Gastroenterol 1998;93:2113-18. (Pubitemid 29076860)
40. Shibata A, Matsuda T, Ajiki W, Sobue T. Trend in incidence of adenocarcinoma of the esophagus in Japan, 1993-2001. Jpn J Clin Oncol 2008;38:464-8.
41. Okabayashi T, Gotoda T, Kondo H, Inui T, Ono H, Saito D, et al. Early carcinoma of the gastric cardia in Japan: is it different from that in the West? Cancer 2000;89: 2555-9. (Pubitemid 32011598)
42. Skinner DB, Walther BC, Riddell RH, Schmidt H, Iascone C, DeMeester TR. Barrett's esophagus. Comparison of benign and malignant cases. Ann Surg 1983;198:554-65.
43. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985;313:857-9. (Pubitemid 15250200)
44. Hameeteman W, Tytgat GN, Houthoff HJ, van den Tweel JG. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989;96:1249-56. (Pubitemid 19126659)
45. Tytgat GN, Hameeteman W, Onstenk R, Schotborg R. The spectrum of columnar-lined esophagus - Barrett's esophagus. Endoscopy 1989;21:177-85.
46. Hongo M, Shoji T. Epidemiology of reflux disease and CLE in East Asia. J Gastroenterol 2003;38Suppl 15:25-30. (Pubitemid 36442881)
47. Azuma N, Endo T, Arimura Y, Motoya S, Itoh F, Hinoda Y, et al. Prevalence of Barrett's esophagus and expression of mucin antigens detected by a panel of monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma in Japan. J Gastroenterol 2000;35:583-92. (Pubitemid 30649494)